GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AtriCure Inc (NAS:ATRC) » Definitions » Cyclically Adjusted PB Ratio

AtriCure (AtriCure) Cyclically Adjusted PB Ratio : 2.95 (As of Apr. 29, 2024)


View and export this data going back to 2005. Start your Free Trial

What is AtriCure Cyclically Adjusted PB Ratio?

As of today (2024-04-29), AtriCure's current share price is $23.37. AtriCure's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 was $7.93. AtriCure's Cyclically Adjusted PB Ratio for today is 2.95.

The historical rank and industry rank for AtriCure's Cyclically Adjusted PB Ratio or its related term are showing as below:

ATRC' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 2.92   Med: 8.65   Max: 26.04
Current: 2.92

During the past years, AtriCure's highest Cyclically Adjusted PB Ratio was 26.04. The lowest was 2.92. And the median was 8.65.

ATRC's Cyclically Adjusted PB Ratio is ranked worse than
63.38% of 456 companies
in the Medical Devices & Instruments industry
Industry Median: 2.1 vs ATRC: 2.92

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

AtriCure's adjusted book value per share data for the three months ended in Dec. 2023 was $9.809. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $7.93 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


AtriCure Cyclically Adjusted PB Ratio Historical Data

The historical data trend for AtriCure's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AtriCure Cyclically Adjusted PB Ratio Chart

AtriCure Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.54 12.17 12.10 6.34 4.50

AtriCure Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.34 5.68 6.53 5.60 4.50

Competitive Comparison of AtriCure's Cyclically Adjusted PB Ratio

For the Medical Instruments & Supplies subindustry, AtriCure's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AtriCure's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AtriCure's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where AtriCure's Cyclically Adjusted PB Ratio falls into.



AtriCure Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

AtriCure's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=23.37/7.93
=2.95

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AtriCure's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, AtriCure's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book=Book Value per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=9.809/129.4194*129.4194
=9.809

Current CPI (Dec. 2023) = 129.4194.

AtriCure Quarterly Data

Book Value per Share CPI Adj_Book
201403 4.900 99.695 6.361
201406 4.886 100.560 6.288
201409 4.916 100.428 6.335
201412 4.806 99.070 6.278
201503 4.533 99.621 5.889
201506 4.510 100.684 5.797
201509 4.411 100.392 5.686
201512 5.784 99.792 7.501
201603 5.472 100.470 7.049
201606 5.331 101.688 6.785
201609 5.217 101.861 6.628
201612 5.052 101.863 6.419
201703 4.738 102.862 5.961
201706 4.705 103.349 5.892
201709 4.610 104.136 5.729
201712 4.660 104.011 5.798
201803 4.370 105.290 5.372
201806 4.522 106.317 5.505
201809 4.593 106.507 5.581
201812 6.460 105.998 7.887
201903 6.190 107.251 7.469
201906 6.231 108.070 7.462
201909 6.529 108.329 7.800
201912 6.237 108.420 7.445
202003 5.673 108.902 6.742
202006 9.276 108.767 11.037
202009 9.274 109.815 10.930
202012 9.094 109.897 10.710
202103 8.576 111.754 9.932
202106 8.393 114.631 9.476
202109 10.634 115.734 11.891
202112 10.513 117.630 11.567
202203 10.003 121.301 10.672
202206 9.838 125.017 10.184
202209 9.696 125.227 10.021
202212 9.809 125.222 10.138
202303 9.628 127.348 9.785
202306 9.766 128.729 9.818
202309 9.766 129.860 9.733
202312 9.809 129.419 9.809

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


AtriCure  (NAS:ATRC) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


AtriCure Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of AtriCure's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


AtriCure (AtriCure) Business Description

Traded in Other Exchanges
N/A
Address
7555 Innovation Way, Mason, OH, USA, 45040
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States.
Executives
Karl S. Dahlquist officer: Chief Legal Officer 7555 INNOVATION WAY, MASON OH 45040
Karen Prange director 1108 S RIO VISTA BLVD, FORT LAUDERDALE FL 33316
Maggie Yuen director ONE PENUMBRA PLACE, ALAMEDA CA 94502
Vinayak Doraiswamy officer: Chief Scientific Officer 7555 INNOVATION WAY, MASON OH 45040
Deborah Lee Yount officer: Chief Human Resources Officer 7555 INNOVATION WAY, MASON OH 45040
Tonya Austin officer: Chief Human Resources Officer 7555 INNOVATION WAY, MASON OH 45040
Angela L Wirick officer: Chief Financial Officer 7555 INNOVATION WAY, MASON OH 45040
Mark A Collar director 382 BISHOPBRIDGE DR, CINCINNATI OH 45255
Regina E Groves director 5751 COPLEY DRIVE, SAN DIEGO CA 92111
Douglas J Seith officer: SVP of Sales and Marketing 7555 INNOVATION WAY, MASON OH 45040
Salvatore Privitera officer: VP; Product Development 7555 INNOVATION WAY, MASON OH 45040
Justin J Noznesky officer: SVP, Mktg & Business Develop 7555 INNOVATION WAY, MASON OH 45040
Deborah H Telman director 2000 GALLOPING HILL ROAD, KENILWORTH NJ 07033
Scott William Drake director 9965 FEDERAL DRIVE, COLORADO SPRINGS CO 80921
Sven Wehrwein director